HSBC Holdings’s Gossamer Bio GOSS Stock Holding History

HSBC Holdings’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$267K	Buy	19,789 +18,365	+1,290%	+$410K	﹤0.01%	2578
2026 Q1	$37.8K	Buy	+1,424	New	+$179K	﹤0.01%	2825
2025 Q4	–	Sell	-325	Closed	-$68.2K	–	3023
2025 Q3	$68.2K	Buy	325 +99	+44%	+$17.5K	﹤0.01%	2625
2025 Q2	$23K	Buy	+226	New	+$19.7K	﹤0.01%	2973
2021 Q1	–	Sell	-150	Closed	-$117K	–	2887
2020 Q4	$117K	Buy	+150	New	+$118K	﹤0.01%	2930
2020 Q3	–	Sell	-131	Closed	-$136K	–	2782
2020 Q2	$136K	Buy	+131	New	+$132K	﹤0.01%	2469
2019 Q4	–	Sell	-266	Closed	-$357K	–	3097
2019 Q3	$357K	Buy	+266	New	+$423K	﹤0.01%	2519

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

HSBC Holdings's GOSS Position: Q2 2026 in Review

HSBC Holdings increased its Gossamer Bio (GOSS) stake by 1,290% in Q2 2026, buying an estimated $410K and bringing the position to 19,789 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #2578.

HSBC Holdings first reported a position in GOSS in Q3 2019 and has held it in 7 quarters since. The position peaked at $357K in Q3 2019. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

HSBC Holdings held 19,789 shares of Gossamer Bio worth $267K as of Q2 2026.
HSBC Holdings bought 18,365 Gossamer Bio shares in Q2 2026, an estimated $410K.
Gossamer Bio made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2578 holding.
HSBC Holdings first reported a position in Gossamer Bio in Q3 2019 and has held it in 7 quarters since.
HSBC Holdings's Gossamer Bio position peaked at $357K in Q3 2019.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.